• HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
Type and hit ENTER
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
GET CONNECTED
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
ProAxsis receives Royal visit
Share
News, ProteaseTag®

ProAxsis receives Royal visit

October 19, 2016
-
Posted by Webmaster

ProAxsis were this week delighted to host His Royal Highness, the Duke of York, at their new laboratory facilities within the Concourse III building at Catalyst Inc. Prince Andrew, who is Patron of Catalyst Inc., spent time meeting the team at ProAxsis, as well as finding out more details about the company’s novel ProteaseTag® technology, which allows for the detection and measurement of active protease biomarkers of disease. The company is currently focused on the measurement of neutrophil elastase, as a biomarker of lung infection and inflammation in chronic respiratory diseases, such as cystic fibrosis, bronchiectasis and COPD.

For further information about the company and its core technology, please visit www.proaxsis.com or contact us via info@77.104.171.207

ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University.


October 19, 2016

Related News

Other posts that you should not miss.
Neutrophil Elastase Immunoassay, ProteaseTag®

ProAxsis appoints first distributor for NE Immunoassay

September 14, 2017
-
Posted by Webmaster

ProAxsis today announces that the company has appointed Diagenics Limited as the distributor for its ProteaseTag® Active Neutrophil …

Read More
September 14, 2017
Posted by Webmaster
News

ProAxsis receives further backing from Invest Northern Ireland under EU investment

June 1, 2018
-
Posted by David Ribeiro

ProAxsis Limited has received an Invest NI Grant for Research and Development, supporting the company to develop new …

Read More
June 1, 2018
Posted by David Ribeiro
Conferences, News

ProAxsis team to attend BIO 2016

June 2, 2016
-
Posted by Webmaster

ProAxsis will be attending the BIO 2016 conference, taking place at the Moscone Convention Center in San Francisco between …

Read More
June 2, 2016
Posted by Webmaster
← PREVIOUS POST
ProAxsis to present at 2016 North American Cystic Fibrosis Conference
NEXT POST →
ProAxsis gains CE Mark for Active Neutrophil Elastase Immunoassay
Categories
  • Announcements
  • Conferences
  • NEATstik®
  • Neutrophil Elastase Immunoassay
  • News
  • ProteaseTag®
  • Trials
  • Video
GET CONNECTED
RECENT POSTS
  • ProAxsis Limited appoints first distributor for DACH region
    December 14, 2020

    ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active …

  • ProAxsis Limited supported by Innovate UK to accelerate work on inflammatory biomarkers associated with COVID-19
    December 10, 2020

    ProAxsis (www.proaxsis.com), the Belfast-based respiratory diagnostics company, today announces that it has been …

  • ProAxsis Limited recognised as Gold Level Innovator by Innovate NI
    December 2, 2020

    ProAxsis (www.proaxsis.com), the Belfast-based protease diagnostics company, is delighted to announce that it …


ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland

tel +44 (0)28 9073 0444
email info@proaxsis.com

RECENT NEWS
  • February 21, 2021
    ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases
  • December 14, 2020
    ProAxsis Limited appoints first distributor for DACH region
  • December 10, 2020
    ProAxsis Limited supported by Innovate UK to accelerate work on inflammatory biomarkers associated with COVID-19
LATEST TWEETS
Twitter
ProAxsis
Follow Me
ProAxsis is delighted to have received this support from Innovate UK - https://t.co/toTxOz9KK6
124 days ago
- ProAxsis
RT @GRobinsonDUP: I’m delighted that @ProAxsis based in East Belfast have been successful in their application for an Innovate UK Grant, wh…
124 days ago
- ProAxsis
We are delighted to announce that as of today, we have appointed an exclusive distributor for our portfolio of prod… https://t.co/rmCmIugsLa
145 days ago
- ProAxsis
Due to our continued expansion, we wish to recruit an Administration Officer. This post can be full-time or part-ti… https://t.co/k3wKwVfOKy
165 days ago
- ProAxsis
Copyright © 2016-2021 - ProAxsis - All rights reserved. 
ProAxsis receives Royal visit | ProAxsis